Publications
Retrouvez ici les dernières publications scientifiques relatives aux études et travaux menés par Santé publique France.
48 publications
article
Global impact of ten-valent and 13-valent pneumococcal conjugate vaccines on invasive pneumococcal disease in all ages (the PSERENADE project): a global surveillance analysis
enquêtes/études
Surveillance des infections associées aux dispositifs invasifs. Mission nationale SPIADI. Résultats de la surveillance menée en 2021
enquêtes/études
Épidémie d'infections à Streptococcus pyogenes (SGA) emm60.11 dans une communauté SDF toxicomane de la métropole lilloise, août 2020 - avril 2022. Rapport d'investigation et de gestion
article
Invasive pneumococcal infections in France: changes from 2009 to 2021 in antibiotic resistance and serotype distribution of Streptococcus pneumoniae based on data from the French Regional Pneumococcal Observatories network
article
Association of Nonpharmaceutical Interventions During the COVID-19 Pandemic With Invasive Pneumococcal Disease, Pneumococcal Carriage, and Respiratory Viral Infections Among Children in France
article
Effectiveness of 10 and 13-valent pneumococcal conjugate vaccines against invasive pneumococcal disease in European children: SpIDnet observational multicentre study
article
Changes in invasive pneumococcal disease caused by streptococcus pneumoniae Serotype 1 following introduction of PCV10 and PCV13: findings from the PSERENADE project
article
Invasive pneumococcal disease incidence in children and adults in France during the pneumococcal conjugate vaccine era: an interrupted time-series analysis of data from a 17-year national prospective surveillance study
article
Socioeconomic disparities associated with 29 common infectious diseases in Sweden, 2005-14: an individually matched case-control study
article
Outbreak of pneumococcal pneumonia among shipyard workers in Marseille, France, January to February 2020
En relation avec
Vaccination
dossier thématique
Les maladies contagieuses touchent le plus souvent les enfants très tôt dans la vie. Ces derniers, particulièrement fragiles, sont donc une cible prioritaire des programmes de vaccination.
